Primary sjögren's syndrome as a multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients

Rheumatology (United Kingdom)

Volumn 53, Issue 5, 2014, Pages 839-844

  Baldini, Chiara ^a   Pepe, Pasquale ^a   Quartuccio, Luca ^b   Priori, Roberta ^c   Bartoloni, Elena ^d   Alunno, Alessia ^d   Gattamelata, Angelica ^c   Maset, Marta ^b   Modesti, Mariagrazia ^c   Tavoni, Antonio ^a   De vita, Salvatore ^b   Gerli, Roberto ^d   Valesini, Guido ^c   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Disease severity; Epidemiology; Sj gren's syndrome

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ACUTE MOTOR AXONAL NEUROPATHY; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; CRYOGLOBULINEMIA; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; HEALTH IMPACT ASSESSMENT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ITALY; LEUKOCYTOCLASTIC VASCULITIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SJOEGREN SYNDROME; SYNOVITIS;

EID: 84902551370     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket427     Document Type: Article

References (20)

1. Skopouli FN, Dafni U, Ioannidis JP et al. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 2000;29:296-304.
2. Quartuccio L, Salvin S, Fabris M et al. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology 2013;52: 276-81.
3. Bowman SJ. Biologic therapies in primary Sjogren's syndrome. Curr Pharm Biotechnol 2012;13:1997-2008.
4. Baldini C, Pepe P, Luciano N et al. A clinical prediction rule for lymphoma development in primary Sjogren's syndrome. J Rheumatol 2012;39:804-8.
5. Theander E, Henriksson G, Ljungberg O et al. Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
6. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
7. Bournia VK, Diamanti KD, Vlachoyiannopoulos PG et al. Anticentromere antibody positive Sjogren's syndrome: a retrospective descriptive analysis. Arthritis Res Ther 2010; 12:R47.
8. Baldini C, Mosca M, Della Rossa A et al. Overlap of ACA positive systemic sclerosis and Sjogren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol 2013;31: 272-80.
9. Pertovaara M, Pukkala E, Laippala P et al. A longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001;60:467-72.
10. Alamanos Y, Tsifetaki N, Voulgari PV et al. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology 2006;45:187-91.
11. Garcia-Carrasco M, Ramos-Casals M, Rosas J et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 2002; 81:270-80.
12. Ramos-Casals M, Solans R, Rosas J et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008;87: 210-9.
13. Seror R, Mariette X, Bowman S et al. Accurate detection of changes in disease activity in primary Sjogren's syndrome by the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index. Arthritis Care Res 2010; 62:551-8.
14. Bombardieri S, Paoletti P, Ferri C et al. Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979;66: 748-56.
15. Wu DH, Tavoni A, Garzelli C et al. A simple method for the biochemical purification of Ro/SS-A antigen. J Immunol Methods 1989;121:219-24.
16. Martel C, Gondran G, Launay D et al. Active immunological profile is associated with systemic Sjogren's syndrome. J Clin Immunol 2011;31:840-7.
17. Solans-Laque R, Lopez-Hernandez A, Bosch-Gil JA et al. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjogren's syndrome. Semin Arthritis Rheum 2011;41:415-23.
18. Voulgarelis M, Ziakas PD, Papageorgiou A et al. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome. Medicine 2012;91:1-9.
19. Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M et al. Sjogren syndrome or sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 2010;38:178-85.
20. Shiboski SC, Shiboski CH, Criswell L et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012;64: 475-87.